From: Risk-reducing salpingo-oophorectomy: a meta-analysis on impact on ovarian cancer risk and all cause mortality in BRCA 1 and BRCA 2 mutation carriers
Study (country)
Patients with/without RRSO
Follow-up (years)
Age at RRSO (mean)
All
BRCA1
BRCA2
Kauff et al. [13] (USA)
509/283
325/173
184/110
3.4
47.1
Domchek et al. [10] (USA)
939/1678
681/1006
258/672
6.2
43.2
Finch et al. [6] (USA-Europe)
3513/2270
2649/1824
864/446
5.6
47.75
